Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as “relapsing” or “progressive.” An international study, published on August 20, 2025, in Nature Medicine under ...
The role that Epstein-Barr Virus (EBV) plays in the development of Multiple Sclerosis may be caused a higher level of cross-reactivity, where the body's immune system binds to the wrong target, than ...
A biological, mechanism-based framework to reclassify multiple sclerosis (MS) types was proposed by the International Advisory Committee on Clinical Trials in Multiple Sclerosis. The approach lays the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback